Despite numerous advances in interventional radiology and vascular surgery, the clinician continues to be confronted with inoperable vascular disease. Previous studies have shown that ulceration associated with a transcutaneous oxygen pressure (tcPO 2 ) of Ͻ20 mmHg is refractory to all attempts at healing. External pneumatic compression for the treatment of peripheral vascular disease has been available for several years, although there is a relative paucity of data regarding its role in clinical practice as well as its efficacy. The objective of this study was to examine the experience with circulator boot therapy in the treatment of ischemic ulcers in the absence of osteomyelitis, and specifically to determine whether such therapy can be of benefit in ischemic limb ulceration associated with a tcPO 2 of Ͻ20 mmHg. A retrospective chart review was undertaken of all patients with a lower limb ulcer who, in the absence of osteomyelitis, underwent circulator boot therapy at the Gonda Vascular Center. A total of 98 patients was identified. Two patients died within 1 month of commencing therapy and were not included in further analysis. The tcPO 2 data were unavailable in five patients. Outcome in the patient population was classified as favorable if (1) healing was achieved, (2) the ulcer decreased in size, or (3) the affected limb improved sufficiently to allow successful revascularization. An unfavorable outcome was one where a major amputation was performed or where the ulcer increased in size. Out of a total of 29 patients with a tcPO 2 Ͻ20 mmHg at the area of ulceration, 19 had a favorable outcome following circulator boot therapy. Of the remaining 62 patients with a tcPO 2 Ͼ20 mmHg, 54 had a favorable outcome. Circulator boot therapy is associated with improved outcomes in limb ulceration due to peripheral vascular disease. Complete ulcer healing as well as preservation of the affected limb can be achieved in most cases.
Introduction
Ulceration develops in the extremities when there is an imbalance between the metabolic demands of cutaneous tissues and the ability of the circulation to provide the necessary oxygen and other nutrients. This imbalance leads to ulceration and breakdown of the skin, a process that, if unchecked, will lead to loss of the extremity.
Revascularization forms the mainstay of therapy for arterial insufficiency. This is performed using conventional bypass procedures or angiographic techniques. However, this therapy is not applicable to all cases of circulatory insufficiency: significant proportions of patients presenting with limb ulceration have inoperable vascular disease. Other co-morbidities, such as cerebrovascular and coronary heart disease, may also contraindicate surgical intervention.
For these reasons, clinicians continue to be confronted with limbs that require amputation because of severe peripheral vascular disease that cannot be revascularized.
The circulator boot
The earliest attempts at increasing peripheral circulation involved the manipulation of external limb pressure. In 1832, Sir James Murray observed that the application of an external vacuum to the skin instantly increased cutaneous circulation so that 'the skin became instantly hot, turgid and red'. This therapy was applied (unsuccessfully) to the treatment of patients with cholera. 1 Subsequently, several attempts at improving peripheral circulation have applied positive and/or negative pressure to the affected limb. Allwood 2 and Loane, 3 working independently, were able to demonstrate that venous pressure in the foot is lowered and blood flow is increased in seated subjects with and without vascular disease undergoing intermittent calf compression.
In a patient with a compromised peripheral circulation, blood flow to the leg is greatest in the dependent position, and at its lowest when the leg is elevated above the heart. This principle is illustrated by Buerger's test. (Buerger's test is a simple and reliable test of the integrity of the peripheral vascular system. With the patient supine, the leg is elevated above the level of the heart. The development of pallor implies compromise of the circulation to the leg. This is accompanied by the development of dependent rubor when the limb is subsequently hung over the side of the bed below the level of the heart.) Conversely, patients with critical ischemia and rest pain often obtain relief by hanging their leg over the side of the bed. However, when a subject is in the seated position, an increase in hydrostatic pressure produces equal rises in arterial and venous pressure. Prolonged dependency in a limb with circulatory insufficiency is therefore accompanied by edema. This is detrimental to the microcirculation and offsets the benefits of dependency. Continuous external pressure applied to the dependent limb would prevent the development of edema, but this can only be achieved at the cost of increased resistance to an already compromised arterial blood flow.
Application of intermittent external pressure to the leg overcomes this disadvantage. Increased blood flow occurs in a manner analogous to that produced by the pumping action of the calf muscles during walking. External compression briefly raises tissue pressure, emptying the underlying veins and transiently reducing venous pressure without occluding arterial blood flow. Dillon has demonstrated significant augmentation of pulse volume recordings in reclining patients undergoing cardiosynchronous compression of the limb from foot to groin. 4 The circulator boot is a device that encircles the entire limb and applies external pressures approximating diastolic blood pressure. Compression (55-80 mmHg) is timed to coincide with end-diastole and therefore to contribute to maximal venous emptying while enhancing forward flow of blood to the limb in systole. The compression cycle is triggered electrically by the R-wave with a delay time to allow for distal propagation of the pulse wave. Decompression occurs prior to systole in order to (1) maximally reduce afterload and (2) ensure that the arrival of the next pulse wave in the limb is met with no interference from the boot. Applied pressure is limited to diastolic blood pressure. This is done to avoid the expulsion of arterial blood from the leg with subsequent worsening of ischemia.
The beneficial effects of external compression may also include the release of endothelial factors with local and systemic effect. Metabolites of prostacyclin (PGI 2 ) are present in increasing concentrations in patients undergoing pneumatic compression of a limb. The clinical significance of this is unknown. 1, 4 
Non-invasive assessment of the peripheral circulation -tcPO 2
Transcutaneous oxygen tension (tcPO 2 ) measurements, by means of an electrode attached to the skin, provide a functional assessment of cutaneous blood flow. A skin electrode measures oxygen tension as O 2 diffuses from the superficial regions of the skin. Under conditions of high skin blood flow, tcPO 2 approaches arterial PO 2 . If arterial blood flow to the skin falls relative to metabolic needs, the tcPO 2 will decrease. A similar drop in tcPO 2 will occur if the metabolic rate is increased relative to the oxygen delivery. Transcutaneous oxygen tension represents a functional assessment of the match between cutaneous O 2 delivery and O 2 demand and is used to quantify the degree of ischemia in poorly perfused skin.
To ensure that the measured tcPO 2 reflects true vessel patency and not vasoconstriction, the electrode incorporates a heating element, which warms the skin to a temperature of 45°C, causing maximal dilation of the small cutaneous vessels beneath the electrode. The O 2 measurements require about 20 min to come to a constant value. 5 During tcPO 2 measurement, an electrode is placed on the chest and used as a reference site for all tcPO 2 measurements. After tcPO 2 is measured in the supine position, the legs are elevated 30°for 3 min; this may produce or intensify tcPO 2 abnormalities not noted while supine.
Bacharach et al 6 demonstrated that 98% of clean surgical amputation sites associated with a tcPO 2 Ͼ40 mmHg heal, whereas those associated with a tcPO 2 Ͻ20 mmHg essentially never heal unless the tcPO 2 is improved, for example by revascularization. Similarly, in the same study, 33% of patients with a tcPO 2 between 20 and 40 mmHg failed to heal.
It has been hoped that the improvement in peripheral circulation obtained by circulator boot treatment would allow healing to occur in patients with reduced tcPO 2 and therefore alter the natural history of wound healing.
Patients and methods
The 98 patients selected for this analysis had ischemic ulceration of a limb that was not immediately amenable to surgical or endovascular intervention. In some patients, such procedures could not be performed due to co-morbidities such as pneumonia or myocardial infarction at the time of presentation. Other patients were not candidates for intervention because of unsuitable anatomy for revascularization.
None of the patients had documented osteomyelitis. In our practice, we screen for osteomyelitis using plain radiography of the affected limb. If any abnormalities of the bone underlying the area of ulceration are noted, magnetic resonance imaging is obtained to confirm or exclude the presence of osteomyelitis, allowing appropriate treatment.
All the patients underwent circulator boot therapy (one or two sessions per day, each session 45 min in duration) at the Gonda Vascular Center. In addition to circulator boot therapy, all patients received standard local treatment to the ulcer. Antibiotic treatment was prescribed for the treatment of local infection or signs of systemic toxicity. On average, patients received 40 days of circulator boot treatment. Measurements of tcPO 2 values were obtained in all patients at the start of treatment.
All patients received regular follow-up at the Gonda Vascular Center, where the ulcer was photographed and the ulcer area measured. The mean duration of follow-up after commencement of circulator boot therapy was 50 weeks for all patients.
A total of 98 patients receiving prescribed circulator boot treatment were studied; 36 of these patients were initially treated with the circulator boot (usually for 1-3 weeks) and were then switched to a home program that used an impulse-type intermittent pneumatic pump. Only patients showing a favorable response to the initial course of circulator boot therapy were considered for home pumping. The pumps (AIRCAST® Arterio Flow™ or PlexiPulse® by NuTech®) utilized an inflatable cuff that wrapped around the affected foot and/or leg. The cuffs were typically inflated every 20 s to a pressure of 100 mmHg or more; the inflation was held for 2-3 s and was not applied in a cardiosynchronous fashion. Patients were instructed to use (Table 1) . For study purposes, the outcome was considered to be favorable if the ulcer was skin grafted successfully, if the limb could subsequently be revascularized successfully, or if the ulcer healed completely, decreased significantly in size, or remained stable in size. The decision to consider an ulcer that remains stable in size as a 'favorable' outcome can be justified on the grounds that untreated ischemic ulceration is a dynamic process whose natural history usually leads to loss of the affected limb through infection and gangrene. In general, an untreated ulcer in an ischemic limb (tcPO 2 Ͻ40 mmHg) will enlarge with time, providing a portal of entry for infection that eventually leads to limb loss. Consequently, stabilization of an ulcer's size was considered to be a favorable outcome in this study.
Conversely, a major amputation (above knee, below knee or forefoot) of the affected limb, or an increase in the size of the ulcer (while on treatment) were considered to be unfavorable outcomes.
Results
The characteristics of the population under study are outlined in Table 2 . A total of 98 patients received circulator boot therapy at the Gonda Vascular Center for ischemic limb ulceration in the absence of osteomyelitis. Two patients died within 1 month of undergoing circulator boot therapy; one of these patients experienced an asystolic cardiac arrest while the other patient died of congestive cardiac failure. Neither patient was included in further analysis. In five patients, tcPO 2 data were unavailable. Using the outcome criteria described above, a total of 77 patients had a favorable outcome, while 19 patients had an unfavorable outcome. Of the latter group, the ulcer under treatment enlarged in two patients. Fifteen patients required amputation. The two patients whose ulcer enlarged while on treatment, and eight of the remainder, had a supine tcPO 2 Ͻ20 mmHg.
In the group with a favorable outcome, 19 had a supine tcPO 2 Ͻ20 mmHg: complete healing was achieved in four; and the ulcer decreased in size in another six; and the remaining nine patients were subsequently revascularized successfully.
Of the remaining 58 patients with a favorable outcome, four never had measurement of tcPO 2 at the site of ulceration and 54 had a tcPO 2 Ͼ20 mmHg. There was no change in size of the ulcer in seven patients. The ulcer decreased in size in 18 patients. Five patients in this group were revascularized and another three grafted successfully. Complete healing was achieved in the remaining 21 patients.
Of the 36 patients who used a home pump, eight out of 36 (22.2%) had an unfavorable outcome. Of the 60 patients who did not use a home pump, 11 out of 60 (18.3%) patients had an unfavorable outcome (p = 0.64 by chisquare test).
Discussion
Leg ulcers are more common in the elderly and their prevalence is likely to rise as the average age of a population increases. The financial and social burdens of treating leg ulcers are immense because of the loss of independence that patients experience as well as the frequent hospital visits associated with appropriate wound care. One must also note that limb loss does not come without significant morbidity and mortality as well as financial and social burdens. The perceived expense of treating limb ulceration should therefore be tempered with the realization that caring for an amputee carries its own financial and emotional burdens.
In the western world, venous ulcers are the commonest type of leg ulcer, accounting for approximately 80-90% of cases. Arterial disease accounts for another 5-10%. The majority of the remainder are neuropathic ulcers. 7 In our review of the Mayo Clinic circulator boot experience we have concentrated on those patients undergoing circulator boot therapy whose ulceration was predominantly ischemic in origin. Patients with underlying osteomyelitis were excluded from the analysis. Bacharach 6 has shown that in a population with 'clean' surgical wounds (amputation sites), healing will not occur with a tcPO 2 Ͻ20 mmHg and will be delayed when tcPO 2 is 20-40 mmHg ( Table 3 ). The ulcers in our population were heterogeneous in nature, and in the setting of peripheral vascular disease were more likely to get infected or exhibit delayed healing. This would make the significant (pϽ0.05) and favorable differences in outcome observed with circulator boot therapy all the more remarkable (Table 4 ). Supine tcPO 2 values in this population were below 40 mmHg (the value above which healing is expected) in 63.7% of patients (mean supine tcPO 2 30.3 mmHg). In 17 patients, circulator boot therapy was used as a bridge to revascularization or skin-grafting -procedures which could not be performed immediately in most of these patients owing to other co-morbidities or wound infection at the time of presentation.
Circulator boot therapy achieved complete healing in 25 patients who were not candidates for any therapy other than amputation. The tcPO 2 was Ͻ20 mmHg in four, between 20 and 40 mmHg in another seven and Ͼ40 mmHg in the remaining 14. This represents a marked improvement in the rate of healing over that predicted by Bacharach's data ( Table 4) .
As previously mentioned, home pump therapy was used by an identical percentage of patients in each outcome category (p = 0.64 by chi-square test). In this study (which was not designed to study the effect of home pump therapy), this therapeutic modality did not seem to have additional benefits on the outcome of ischemic limb ulceration after circulator boot therapy.
Although complete healing was not achieved in 31 patients (the ulcer grew larger in two), this subgroup of patients had severe peripheral ischemia (tcPO 2 Ͻ20 in six and between 20 and 40 mmHg in 13). Many had previously undergone revascularization procedures. None was a candidate for further therapy.
Patients with unfavorable outcomes had lower tcPO 2 values as well as higher creatinine levels (Table 5 ) when compared with those with favorable outcomes. The significance of these parameters in predicting the success of circulator boot therapy has yet to be determined prospectively. Uremia is known to have significant adverse effects on vessel wall biology and tissue repair.
It is likely that the elevated creatinine seen in those patients with an unfavorable outcome is a manifestation of this phenomenon. Patients with elevated serum creatinine are more likely to have calcified vessel walls, hypertension and small vessel disease. All of these factors adversely affect wound healing.
Limitations
This study is a retrospective review of the experience with circulator boot therapy at the Gonda Vascular Center. It is limited by its retrospective nature and the absence of an established, unified treatment protocol for boot therapy at the time of study. Furthermore, no control group for circulator boot therapy was established. This limitation has been addressed by comparison with our previous outcome data for a given tcPO 2 measurement at an amputation site. 6 The patients utilized for this review had ulceration that was predominantly ischemic in origin. Those patients with underlying osteomyelitis were excluded from the analysis. As such, the favorable results obtained with boot therapy cannot be generalized to the therapy of all ulcers refractory to conventional therapy.
Conclusion
Circulator boot therapy is a useful adjunct in the management of ischemic ulceration that is not amenable to revascularization and/or skin grafting. Our data suggest that partial or complete ulcer healing can be achieved even with tcPO 2 values consistently below 40 mmHg. The circulator boot may also be used as a bridge to further intervention that may not be possible at the time of presentation owing to treatable co-morbidities.
Although external pneumatic compression of a limb has Vascular Medicine 2000; 5: 21-25 limited availability at the present time, its potential limbsaving benefits deserve wider application in the treatment of ulcers. The benefits of limb salvage and preservation of a patient's mobility and independence far outweigh the disadvantages of this treatment in selected patients.
